Czechia· CZ-0252540
ONTOZRY
A cenobamate product containing cenobamate, registered in Czechia by Angelini Pharma S.p.A, Rome. The same ATC class is registered in 15 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Cenobamate is registered in 15 of 19 countries.
Countries holding a registration under ATC N03AX25 (cenobamate), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 10 of them publish a price we can compare per daily dose
Cenobamate · ATC N03AX25
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of cenobamate costs, country by country.
Normalised to the WHO defined daily dose (0.2 g), the median price runs from $4.11 in France to $21.72 in Switzerland — a ×5.3 gap.
- Czechia: $4.12 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Cenobamate · price per daily dose (0.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$21.72
- IT Italy$19.89
- CZ Czechia$4.12
- FR France$4.11
The record
At a glance
SÚKL (Czech Republic)- Active substance
- CENOBAMATE
- Manufacturer
- Angelini Pharma S.p.A, Rome
- Country
- Czechia (CZ)
- ATC code
- N03AX25
- ATC class
- Cenobamate
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 1
1 priced- cz_kod_sukl025254014CZK 2255.92
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
273 interactions on record for cenobamate.
Graded by severity as the source publishes them — 29 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cenobamate · interactions on record
273 records
- 29 severe
- 237 moderate
- 7 minor
Most severe, free to view
- DeflazacortH02AB13severe
- BosutinibL01EA04severe
- EncorafenibL01EC03severe
- BrigatinibL01ED04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cenobamate in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayOntozryAngelini Pharma S.p.A.
- SwitzerlandOntozry 200 mg, FilmtablettenAngelini Pharma S.p.A., Rom, Zweigniederlassung Zug
- FinlandOntozryOrifarm Oy
- United StatesXcopriSK Life Science, Inc.
- NetherlandsOntozry 200mg, filmomhulde tabletAngelini Pharma S.p.A
- PolandOntozryAngelini Pharma S.p.A.
- SwedenOntozry 200 mg Filmdragerad tablettAngelini Pharma S.p.A.
- IrelandOntozry 200 mg film-coated tabletsAngelini Pharma Italia S.P.A.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Ontozry
- Liechtenstein · Ontozry
- Norway · Ontozry
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c4a7cafb-b2c5-4cb8-9f66-a8c51ba9abe2 GET /v1/drugs/c4a7cafb-b2c5-4cb8-9f66-a8c51ba9abe2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "TBL FLM",
"source": "sukl",
"strength": "200MG",
"pack_size": "14",
"substance": "CENOBAMATE",
"cz_kod_sukl": "0252540",
"product_type": "CH",
"substance_codes": "20789",
"registration_state": "R",
"registration_number": "EU/1/21/1530/011"
}See everything about cenobamate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.